ERBB2 and breast carcinoma: The 12 MBC patients represent all three breast cancer subtypes (estrogen receptor (ER)/progesterone receptor (PR) positive n = 5; human epidermal growth factor receptor 2 (HER2) positive n = 3; triple-negative breast cancer (TNBC) n = 4; Figure 1b).